Bookmark

Add to MyYahoo RSS

Hispanic Broadcasting News

News on Hispanic Broadcasting (Ticker: HSP) continually updated from thousands of sources around the net.

Friday Aug 22 | The Motley Fool

3 Reasons Hospira, Inc. Stock Could Fall

The maker of specialty injectable pharmaceuticals and medical devices has certainly been on fire -- revenue rose 11% year-over-year last quarter as adjusted earnings per share climbed 31%.

Comment?

Related Topix: Television, Food and Drug Administration, North Carolina

Wed Aug 20, 2014

Reuters

U.S. judge blocks FDA rule allowing generic versions of Hospira drug

A federal judge has issued a temporary restraining order against the U.S. Food and Drug Administration's decision to allow the sale of generic versions of the Hospira Inc sedative Precedex.

Comment?

Related Topix: Television, Healthcare Law, Law, Food and Drug Administration

Tue Aug 19, 2014

Seeking Alpha

CareFusion's Strong Share Isn't Quite Enough

CareFusion saw significant margin pressures in 2014 from an acquisition, delayed Pyxis ES installations, and higher infusion capital equipment sales.

Comment?

Related Topix: Biotech, CareFusion, Startups, Omnicell, Television

The Motley Fool

3 Reasons Hospira, Inc. Stock Could Rise

Last quarter, the maker of specialty injectable pharmaceuticals and medical devices reported that its revenue rose 11% year-over-year to $1.1 billion, while its adjusted earnings per share rose 31% to $0.72 per share.

Comment?

Related Topix: Television, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

TheStreet.com

Why Hospira (HSP) Stock Is Lower Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Television, Mozilla, TheStreet, Financial Markets

TheStreet.com

Why Hospira (HSP) Stock Is Lower Today

The FDA approved some applications for generic forms of Precedex, often used to anesthetize patients, and seems ready to grant more, the company said.

Comment?

Related Topix: Television, Financial Markets, Business News

Wall Street Journal

Hospira Sues FDA Over Generic Precedex

Hospira Inc. said Tuesday it has filed a lawsuit against the U.S. Food and Drug Administration to challenge a decision by the agency that made way for the approval of generic Precedex products.

Comment?

Related Topix: Food and Drug Administration, Television

Mon Aug 18, 2014

AmericanBankingNews.com

Insider Selling: Hospira CFO Sells 10,000 Shares of Stock

Hospira CFO Thomas E. Werner sold 10,000 shares of the company's stock in a transaction that occurred on Friday, August 15th.

Comment?

Related Topix: Television

BioSpace

Hospira, Inc. To Present At The Morgan Stanley Global Healthcare Conference

It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's website at www.hospirainvestor.com .

Comment?

Related Topix: Television

Fri Aug 15, 2014

Sys-Con Media

Hospira to Present at the Morgan Stanley Global Healthcare Conference

It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's website at www.hospirainvestor.com .

Comment?

Related Topix: Television

Workforce

When Retaliation Stands the Test of Time

An employer cannot hold a grudge against an employee who engaged in protected activity, with the hope that the passage of time will permit later retaliation.

Comment?

Related Topix: Television

Thu Aug 14, 2014

Reuters

Senior U.S. lawmaker urges Hospira not to flee U.S. tax system

A senior U.S. senator said on Thursday he has written to the chief executive of Hospira Inc and urged the drug and medical device maker not to move its tax domicile abroad to save on U.S. taxes.

Comment?

Related Topix: Television, US Politics, US News, US Senate, Senator Dick Durbin, Lake Forest, IL

Wed Aug 13, 2014

BioSpace

Celltrion, Inc. Files For Approval Of Remicade Biosimilar In US

Celltrion, a Korean biotech, filed with the FDA for approval of RemsimaA , a biosimilar to Janssen's Remicade, which is indicated for autoimmune diseases.

Comment?

Related Topix: Television

JD Supra

Cherry-Picking: 7th Cir. Criticizes Lawyers' Summary-Judgment Practice

Two weeks ago, in an order given wide publicity nationally, federal District Judge Mark Bennett of the Northern District of Iowa issued sanctions in Security National Bank v.

Comment?

Related Topix: Television, Seventh Circuit Court of Appeals, US News

Tue Aug 05, 2014

GlobeNewswire

Premier, Inc. Continues Growth Trajectory With Acquisition of...

Premier, Inc. Continues Growth Trajectory With Acquisition of Hospira's TheraDoc, Expanding Industry Leading Electronic Clinical Surveillance Solutions to Approximately 1,000 Facilities Complementary data analytics and real-time surveillance expertise will support next-generation predictive clinical apps on an integrated technology platform ... (more)

Comment?

Related Topix: Television

Fri Aug 01, 2014

JD Supra

Court Report -- Part III

Cubist Pharmaceuticals Inc. v. Fresenius Kabi USA LLC 1:14-cv-00914; filed July 11, 2014 in the District Court of Delaware Infringement of U.S. Patent Nos.

Comment?

Related Topix: Biotech, Medicine, Cubist Pharmaceuticals, Healthcare Industry, Television, Acorda Therapeutics

Thu Jul 31, 2014

ASHP

Hospira Recalls 2% Lidocaine 5-mL Vials

Hospira Inc. on Tuesday announced the recall of lot 25-550-DD of the company's 2% lidocaine hydrochloride injection in 5-mL vials because of visible particles in the drug solution and iron oxide embedded in the molded glass.

Comment?

Related Topix: Television

Wed Jul 30, 2014

Seeking Alpha

Novartis: The Case Of The Undervalued Biosimilar Pioneer

Most investors, specially when they start looking at this sector, find themselves overwhelmed with information and technical jargon.

Comment?

Related Topix: Biotech, Novartis, Medicine, Healthcare Industry, Teva Pharmaceutical Industries, Television, Amgen

Seeking Alpha

Hospira's (HSP) CEO Michael Ball on Q2 2014 Results - Earnings Call Transcript

I will now turn the call over to Karen King, Corporate Vice President of Investor Relations.

Comment?

Related Topix: Television

Reuters

Hospira beats profit estimates, raises 2014 outlook

Hospira Inc, a pharmaceutical and medical device maker, posted a better-than-expected quarterly profit on higher sales of specialty injectable drugs, and raised its full-year outlook.

Comment?

Related Topix: Television

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••